Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hemostasis Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hemostasis Rapid Tests & Point of Care (POC) prevent and stop bleeding, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview

3 Products under Development

3.1 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
3.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
3.3 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
3.4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date

4 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies

4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
4.2 Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development

5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview

5.1 Atomo Diagnostics Ltd Company Overview
5.1.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Carclo Diagnostic Solutions Ltd Company Overview
5.2.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cascade Metrix LLC Company Overview
5.3.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Edan Instruments Inc Company Overview
5.4.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 EKF Diagnostics Holdings Plc Company Overview
5.5.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Emosis SAS Company Overview
5.6.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Fraunhofer Institute for Cell Therapy and Immunology Company Overview
5.7.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
5.8 Helena Laboratories Corp Company Overview
5.8.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Universal Biosensors Inc Company Overview
5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Appendix

6.1 Methodology
6.2 About the Publisher
6.3 Contact
6.4 Disclaimer

List of Tables

Table 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Table 3: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Table 4: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date
Table 5: Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
Table 6: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Table 7: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

Figure 1: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Stage of Development
Figure 2: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Territory
Figure 3: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Regulatory Path
Figure 4: Hemostasis Rapid Tests & Point of Care (POC) - Pipeline Products by Estimated Approval Date